1. Market Research
  2. > Cancer Industry

Lymphoma Industry, August 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Leukemia, Nuclear Imaging Equipment, Pap Smear, Nuclear Medicine, Bone Marrow Transplant, Cancer Diagnostic, Blood Disease, Immunotherapy, Monoclonal Antibody, Prostate Cancer.


 
1-10 of about 300 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

 B-Cell Lymphomas-Pipeline Insights, 2016

B-Cell Lymphomas-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ B-Cell Lymphomas-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the B-Cell Lymphomas. The De ...

Lymphoma: Analytical Tool

Lymphoma: Analytical Tool

  • $ 7 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Lymphoma Drug Pathway Analyzer

Lymphoma Drug Pathway Analyzer

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 563 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways ...

Target Atlas in Lymphoma: A Competitive Outlook

Target Atlas in Lymphoma: A Competitive Outlook

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product "Target Atlas in Lymphoma: A Competitive Outlook" helps you to understand the complex world of commercial development in lymphoma ...

Lymphoma Drug Pipeline Update

Lymphoma Drug Pipeline Update

  • $ 2 700
  • Company report
  • August 2016
  • by Bioseeker

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 383 companies plus partners developing 568 lymphoma drugs in 1073 developmental projects in cancer. In ...

Treatment of Non-Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Non-Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Non-Hodgkin's lymphoma, also called non-Hodgkin lymphoma, is cancer that originates in your lymphatic system, the disease-fighting network spread throughout your body. In non-Hodgkin's lymphoma, tumors ...

Treatment of Primary CNS Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Primary CNS Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Primary central nervous system (CNS) lymphoma is a non-Hodgkin's lymphoma that arises within and is restricted to the nervous system. It usually presents as a brain tumor, but may also involve the leptomeninges, ...

Treatment of Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

Treatment of Hodgkin Lymphoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Hodgkin lymphoma is considered to be a curable malignancy, but therapies for this disease can have significant long-term toxicity. General treatment modalities include radiation therapy, induction chemotherapy, ...

 Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Anaplastic ...

 Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • August 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous T-Cell ...

About 4 900 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Lymphoma Statistics in the UK

  • July 2016
    182 pages
  • Therapy  

    Lymphoma  

    Chemotherapy  

  • United Kingdom  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.